Phillips-Medisize Adds Drug Handling Capability

Phillips-Medisize has completed a significant expansion at its New Richmond, WI facility, adding capabilities in drug handling for pharmaceutical customers with the complete manufacture of drug delivery devices and compliance with FDA 21 CFR 210/211 requirements.
 
The New Richmond facility will add nearly 70,000 sq.-ft. of space this year to accommodate automation, material handling, robotics and high-tech manufacturing to serve the diagnostics, drug delivery and medical device markets. Additionally, the facility offers services in molding, assembly, labeling, packaging, kitting, serialization, sterilization management and bulk distribution.
 
“This is the second expansion of our New Richmond facility in less than three years. We are excited about the continued growth we are experiencing and the addition of drug handling capabilities we are able to offer our customers at another facility. The expanded drug handling capability will allow Phillips-Medisize to further consolidate the supply chain for our customers,” said Matt Jennings, president Phillips-Medisize.